Instrumentation and probes for molecular and cellular imaging

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 51, Issue 2, 2007, Pages 111-126

  Lecchi, M ^a,b   Ottobrini, L ^a,b   Martelli, C ^a,b   Del Sole, A ^a,b   Lucignani, Giovanni ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Nuclear Medicine Unit   (Italy)

Author keywords

Bioluminescence; Contrast agents; Emission tomography; Magnetic resonance imaging; Molecular imaging

Indexed keywords

9 [FLUORO 3 (HYDROXYMETHYL)BUTYL]GUANINE F 18; CISPLATIN; CONTRAST MEDIUM; ECHO CONTRAST MEDIUM; FLUORESCEIN ISOTHIOCYANATE; FLUOROAZOMYCIN ARABINOSIDE F 18; FLUORODEOXYGLUCOSE F 18; FLUOROETHYLSPIPERONE F 18; FLUOROTHYMIDINE F 18; GEFITINIB; LIPOCORTIN 5 F 18; METHIONINE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG HALF LIFE; DRUG RESPONSE; ECHOGRAPHY; FIBROSARCOMA; FLUOROSCOPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; INTERMETHOD COMPARISON; ISOTOPE LABELING; MEDICAL INSTRUMENTATION; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR IMAGING; MOLECULAR PROBE; NEAR INFRARED FLUOROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; REPORTER GENE; REVIEW; SCINTILLATION PROBE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CELL PHYSIOLOGY; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; FORECASTING; HUMANS; IMAGE ENHANCEMENT; MOLECULAR PROBE TECHNIQUES; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34447581138     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Koo V, Hamilton PW, Williamson K. Non-invasive in vivo imaging in small animal research. Cell Oncol 2006;28:127-39.
2. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-80.
3. Maggi A, Ciana P. Reporter mice and drug discovery and development. Nat Rev Drug Discov 2005;4:249-55.
4. Lewis JS, Achilefu S, Garbow JR, Laforest R, Welch MJ. Small animal imaging: current technology and perspectives for oncological imaging. Eur J Cancer 2002;38:2173-88.
5. Cherry SR. In vivo molecular and genomic imaging: new challenges for imaging physics. Phys Med Biol 2004;49:R13-48.
6. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Looking and listening to fight: the evolution of whole-body photonic imaging. Nat Biotechnol 2005;23:313-20.
7. Levin CS. Primer on molecular imaging technology. Eur J Nucl Med Mol Imaging 2005;32 Suppl 2:S325-45.
8. Ottobrini L, Ciana P, Biserni A, Lucignani G, Maggi A. Molecular imaging: a new way to study molecular processes in vivo. Mol Cell Endocrinol 2006;246:69-75.
9. Contag CH, Bachmann MH. Advances in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 2002;4:235-60.
10. Zhao H, Doyle TC, Coquoz O, Kalish F, Rice BW, Contag CH. Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed Opt 2005;10:41210.
11. Morawski AM, Lanza GA, Wickline SA. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr Opin Biotechnol 2005;16:89-92.
12. Artemov D, Bhujwalla ZM, Bulte JW. Magnetic resonance imaging of cell surface receptors using targeted contrast agents. Curr Pharm Biotechnol 2004;5:485-94.
13. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004;17:484-99.
14. Klibanov AL. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 2006;41:354-62.
15. Pomper MG. Molecular imaging: an overview. Acad Radiol 2001;8:1141-53.
16. Chatziioannou AF. Instrumentation for molecular imaging in preclinical research: micro-PET and nucro-SPECT. Proc Am Thorac Soc 2005;2:533-6, 510-11.
17. Turkington TG. Introduction to PET instruments. J Nucl Med Technol 2001;29:4-11.
18. Schafers KP, Reader AJ, Kriens M, Knoess C, Schober O, Schafers M. Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. J Nucl Med 2005;46:455-63.
19. Phelps AM. Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci U S A 2000;97:9226-33.
20. Couturier O, Luxen A, Chatal JF, Vuillez JP, Rigo P, Hustinx R. Fluorinated tracers for imaging cancer with positron emission tomography. Eur J Nucl Med Mol Imaging 2004;31:1182-206.
21. Aliberti S, Grignani G, Aglietta M. Positron-emission tomography in cancer therapy. N Engl J Med 2006;354:1958-60.
22. Peremans K, Comelissen B, Van Den Bossche B, Audenaert K, Van de Wiele C. A review of small animal imaging planar and pinhole SPECT gamma cameru imaging. Vet Radiol Ultrasound 2005;46:162-70.
23. Beekman FJ, McElroy DP, Berger F, Gambhir SS, Hoffman EJ, ~he!Ty SR. Towards in vivo nuclear microscopy: iodine-125 imaging in mice using micro-pinholes. Eur J Nucl Med Mol Imaging 2002;29:933-8.
24. Leyton J, Latigo JR, Perumal M, Dhaliwal H, He Q, Aboagye EO. Early detection of tumor response to chemotherapy by 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo. Cancer Res 2005;65:4202-10.
25. Solomon B, Binns D, Roselt P, Weibe LI, McArthur GA, Cullinane C et al. Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging. Mol Cancer Ther 2005;4:1417-22.
26. Yagle KJ, Eary JF, Tait JF, Grierson JR, Link JM, Lewellen B et al. Evaluation of F-annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med 2005;46:658-66.
27. Gheysens O, Gambhir SS. Studying molecular and cellular processes in the intact organism. Prog Drug Res 2005;62:117-50.
28. Gross S, Piwnica-Worms D. Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell 2005;7:5-15.
29. Doubrovin M, Serganova I, Mayer-Kuckuk P, Ponomarev V, Blasberg RG. Multimodality in vivo molecular-genetic imaging. Bioconjug Chem 2004;15:1376-88.
30. Dubey P, Su H, Adonai N, Du S, Rosato A, Braun J et al. Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci U S A 2003;100:1232-7.
31. Su H, Forbes A, Gambhir SS, Braun J. Quantitation of cell number by a positron emission tomography reporter gene strategy. Mol Imaging Biol 20G4;6:139-48.
32. Xiong Z, Cheng Z, Zhang X, Patel M, Wu JC, Gambhir SS et al. Imaging chemically modified adenovirus for targeting tumors expressing integrin {alpha}v{beta}3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. J Nucl Med 2006;47:130-9.
33. Welsh DY., Kay SA. Bioluminescence imaging in living organisms. Curr Opin Biotechnol 2005;16:73-8.
34. Rice BW, Cable MD, Nelson MB. In vivo imaging of light-emitting probes. J Biomed Opt 2001;6:432-40.
35. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 2005;23:313-20.
36. Zacharakis G, Kambara H, Shih H, Ripoll J, Grimm J, Saeki Y et al. Volumetric tomography of fluorescent proteins through small animals in vivo. Proc Natl Acad Sci U S A 2005;102:18252-7.
37. Shah K, Weissleder R. Molecular optical imaging: applications leading to the development of present day therapeutics. NeuroRx 2005;2:215-25.
38. Hassan M, Klaunberg BA. Biomedical applications of fluorescence imaging in vivo. Comp Med 2004;54:635-44.
39. Zhao H, Doyle TC, Coquoz O, Kalish F, Rice BW, Contag CH. Emission spectra of bioluminescent reporters and interaction with mammalian times determine the sensitivity of detection in vivo. J Biomed Opt 2005;10:41210.
40. Cao YA, Wagers AJ, Beilhack A, Dusich J, Bachmann MH, Negrin RS et al. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A 2004;101:221-6.
41. Schimmelpfennig CH, Schulz S, Arber C, Baker J, Tamer I, McBride J et al. Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation. Am J Pathol 2005;167:1321-31.
42. Ciana P, Di Luccio G, Belcredito S, Polho G, Vegeto E, Tatangelo L et al. Engineering of a mouse for the in vivo profiling of estrogen receptor activity. Mol Endocrinol 2001;15:1104-13.
43. Ciana P, Raviscioni M, Mussi P, Vegeto E, Que I, Parker MG et al. In vivo imaging of transcriptionally active estrogen receptors. Nat Med 2003;9:82-6.
44. Motz DM, Hewitt SC, Ciana P, Raviscioni M, Lindzey JK, Foley J et al. Requirement of estrogen receptor-alpha in hisulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J Biol Chem 2002;277:8531-7.
45. Di Lorenzo D, Villa R, Biasiotto G, Belloli S, Ruggeri G, Albertini A et al. Isomer-specific activity of dichlorodyphenyltrichloroethane with estrogen receptor in adult and suckling estrogen reporter mice. Endocrinology 2002;143:4544-51.
46. Van der Pluijm G, Que I, Sijmons B, Buijs JT, Lowik CW, Wetterwald A et al. Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo. Cancer Res 2005;65:7682-90.
47. Citrin D, Scott T, Sproull M, Menard C, Tofilon PJ, Camphausen K. In vivo tumor imaging using a near-infrared-labelled endostatin molecule. Int J Radiat Oncol Biol Phys 2004;58:536-41.
48. Ray P, Pimenta H, Paulmurugan R, Berger F, Phelps ME, Iyer M et al. Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc Natl Acad Sci U S A 2002;99:3105-10.
49. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005;307:538-44.
50. Nieman BJ, Bock NA, Bishop J, Chen XJ, Sled JG, Rossant J et al. Magnetic resonance imaging for detection and analysis of mouse phenotypes. NMR Biomed 2005;18:447-68.
51. Bhorade R, Weissleder R, Nakakoshi T, Moore A, Tung CH. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug Chem 2000;11:301-5.
52. Artemov D, Bhujwalla ZM, Bulte JW. Magnetic resonance imaging of cell surface receptors using targeted contrast agents. Curr Pharm Biotechnol 2004;5:485-94.
53. Hinds KA, Hill JM, Shapiro EM, Laukkanen MO, Silva AC, Combs CA et al. Highly efficient endosomal Libeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003;102:867-72.
54. Dodd CH, Hsu HC, Chu WJ, Yang P, Zhang HG, Mountz JD Jr et al. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HEIV transactivator-peptide-derived superparamagnetic nanoparticles. J Immunol Methods 2001;256:89-105.
55. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001;19:1141-7.
56. Kircher AV, Allport JF, Graves EE, Love V, Josephson L, Lichtman AH et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 2003;63:6838-46.
57. Daldrup-Link BE, Meier R, Rudelius M, Piontek G, Piert M, Metz S et al. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol 2005;15:4-13.
58. Maki J, Masuda C, Morikawa S, Morita M, Inubushi T, Matsusue Y et al. The MR tracking of transplanted ATDC5 cells using fluorinated poly-l-lysine-CF(3). Biomaterials 2007;28:434-40.
59. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 gfioma tumors. Neoplasia 2005;7:109-17.
60. Delikatny EJ, Poptani H. MR techniques for in vivo molecular and cellular imaging. Radiol Clin North Am 2005;43:205-20.
61. Price RR, Allison J, Massoth RJ, Clarke GD, Drost DJ; NMR Task Group#8. Practical aspects of functional MRI (NMR Task Group #8). Med Phys 2002;29:1892-912.
62. Moon RB, Richards JH. Determination of intracellular pH by 31P magnetic resonance. J Biol Chem 1973;248:7276-8.
63. Hoult DI, Busby SJ, Gadian DG, Radda GK, Richards RE, Seeley PJ. Observation ot tissue metabolites using P nuclear magnetic resonance. Nature 1974;252:285-7.
64. Choi IY, Lee SP, Guilfoyle DN, Helpern JA. In vivo NMR studies of neurodegenerative diseases in transgenic and rodent models. Neurochem Res 2003;28:987-1001.
65. Chatham JC, Blackband SJ. Nuclear magnetic resonance spectroscopy and imaging in animal research. ILAR J 2001;42:189-208.
66. Nieman BJ, Bock NA, Bishop J, Chen XJ, Sled JG, Rossant J et al. Magnetic resonance imaging for detection and analysis of mouse phenotypes. NMR Biomed 2005;18:447-68.
67. Ritman EL. Micro-computed tomography: current status and developments. Annu Rev Biomed Eng 2004;6:185-208.
68. Paulus MJ, Gleason SS, Easterly ME, Foltz CJ. A review of high-resolution X-ray computed tomography and other imaging modalities for small animal research. Lab Anim (NY) 2001;30:36-45. Erratum in: Lab Anim (NY) 2001;30:13.
69. Kiessling F, Greschus S, Lidry AD, Bock M, Fink C, Vosseler S et al. Volumetric computed tomography (VCI): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis. Nat Med 2004;10:1133-8.
70. Vera DF, Mattrey RF. A molecular CT blood pool contrast agent. Acad Radiol 2002;9:784-92.
71. Ford NL, Graham KC, Groom AC, Macdonald IC, Chambers AF, Holdsworth DW. Time-course characterization of the computed tomography contrast enhancement of an iodinated blood-pool contrast agent in mice using a volumetric flat-panel equipped computed tomography scanner. Invest Radiol 2006;41:384-90.
72. Mattrey RE Blood-pool contrast media are the ideal agents for computed tomography. Invest Radiol 1991;26 Suppl 1:S55-S56.
73. Holdsworth DW, Thornton MM. Micro-CT in small animal and specimen imaging. Trends Biotechnol 2002;20:S34-S39.
74. Krishnamurthi G, Stantz KM, Steinmetz R, Gattone VH, Cao M, Hutchins GD et al. Functional imaging in small animals using X-ray computed tomography: study of physiologic measurement reproducibility. IEEE Trans Med Imaging 2005;24:832-43.
75. Badea CT, Bucholz E, Hedlund LW, Rockman HA, Johnson GA. Imaging methods for morphological and functional phenotyping of the rodent heart. Toxicol Pathol 2006;34:111-7.
76. Lewin PA. Quo vadis medical ultrasound? Ultrasonics 2004;42:1-7. Fenster A, Downey DB, Cardinal HN. Three-dimensional ultrasound imaging. Phys Med Biol. 2001 May;46(5):R67-99.
77. Coatney RW. Ultrasound imaging: principles and applications in rodent research. ILAR J 2001;42:23347.
78. Dawson D, Lygate CA, Saunders J, Schneider JE, Ye X, Hulbert K et al. Quantitative 3-dimensional echocarchography for accurate and rapid cardiac phenotype characterization in mice. Circulation 2004; 110:1632-7.
79. Wirtzfeld LA, Wu G, Bygrave M, Yamasaki Y, Sakai H, Moussa M et al. A new three-dimensional ultrasound microimaging technology for preclinical studies using a transgenic prostate cancer mouse model. Cancer Res 2005;65:633745.
80. Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr Probl Cardiol 2003;28:625-53.
81. Cherin EW, Poulsen JK, van der Steen AF, Lum P, Foster FS. Experimental characterization of fundamental and second harmonic beams for a high-frequency ultrasound transducer. Ultrasound Med Biol 2002;28:63546.
82. Liang HD, Blomley MJ. The role of ultrasound in molecular imaging. Br J Radiol 2003;76 Spec No 2:S140-50.
83. Unger EC, McCreery TP, Sweitzer RH, Caldwell VE, Wu Y. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 1998;33:886-92.
84. Wickline SA, Hughes M, Ngo FC, Hall CS, Marsh JN, Brown PA et al. Blood contrast enhancement with a novel, non-gaseous nanoparticle contrast agent. Acad Radiol 2002;9 Suppl 2:S290-3.
85. Cherry SR. Multimodality in vivo imaging systems: twice the power or double the trouble? Annu Rev Biomed Eng 2006;8:35-62.
86. Hill DL, Batchelor PG, Holden M, Hawkes DJ. Medical image registration. Phys Med Biol 2001;46:R1-45.
87. Chow PL, Stout DB, Komisopoulou E, Chatziioannou AF. A method of image registration for small animal, multi-modality imaging. Phys Med Biol 2006;51:379-90.
88. Rowland DJ, Garbow JR, Laforest R, Snyder AZ. Registration of [F]FDG microPET and small-animal MRI. Nucl Med Biol 2005;32:567-72.
89. Jan ML, Chuang KS, Chen GW, Ni YC, Chen S, Chang CH et al. A three-dimensional registration method for automated fusion of micro PET-CT-SPECT whole-body images. IEEE Trans Med Imaging 2005;24:886-93.
90. Townsend DW, Cherry SR. Combining anatomy and function: the path to true image fusion. Eur Radiol 2001;11:1968-74.
91. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369-79.
92. Beyer T, Townsend DW. Putting 'clear' into nuclear medicine: a decade of PET/CT development. Eur J Nucl Med Mol Imaging 2006;33:857-61.
93. Chow PL, Rannou FR, Chatziioannou AF. Attenuation correction for small animal PET tomographs. Phys Med Biol 2005;50:1837-50.
94. Hasegawa BH, Stebler B, Rutt BK., Martinez A, Gingold EL, Barker CS et al. A prototype high-purity germanium detector system with fast photon-counting circuitry for medical imaging. Med Phys 1991;18:900-9.
95. Boone JM, Velazquez O, Cherry SR. Small-aninial X-ray dose from micro-CT. Mol Imaging 2004;3:149-58.
96. Hammer BE, Christensen NL, Heil BG. Use of a magnetic field to increase the spatial resolution of positron emission tomography. Med Phys 1994;21:1917-20.
97. Shao Y, Cherry SR, Farahani K, Slates R, Silverman RW, Meadors K et al. Development of a PET detector system compatible with MRI/NMR systems. IEEE Trans Nucl Sci 1997;44:1167-71.
98. Farahani K, Slates F, Shao Y, Silverman R, Cherry S. Contemporaneous positron emission tomografy and MR imaging using a prototype MR compatible PET scanner.
99. Ziegler SI, Pilcher BJ, Boening G, Rafecas M, Pimpl W, Lorenz E et al. A prototype high resolution animal positron tomograph with avalanche photodiode arrays and LSO crystal. Eur J Nucl Med 2001;28:136-43.
100. Pilcher BJ, Swann BK, Rochelle J, Nutt RE, Cherry SR, Siegel SB. Lutetium oxyorthosilicate block detector readout by avalanche photodiode arrays for high resolution animal PET. Phys Med Biol 2004;49:4305-19.
101. Pichler BJ, Judenhofer MS, Catana C, Walton JH, Kneilling M, Nutt RE et al. Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. J Nucl Med 2006;47:639-47.
102. Alexandrakis G, Rannou FR, Chatziioannou AF. Effect of optical property estimation accuracy on tomographic bioluminescence imaging: simulation of a combined optical-PET (OPET) system. Phys Med Biol 2006;51:2045-53.
103. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005;23:1407-13.
104. Ray P, De A, Min JJ, Tsien RY, Gambhir SS. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 2004;64:1323-30.